Sanidad de Castilla y Leon Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01389661
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Gerencia Regional de Salud de Castilla y León | Sanidad de Castilla y León | Sanidad de Castilla y Leon (SACYL)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Cysts (Phase 2)

Cysts (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3